Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Thomas Benzing
MEDA-PKD: a dynamic, real-time analytics platform for precision care in autosomal dominant polycystic kidney disease
Abstract The use of medical real-world data is constrained by fragmented data infrastructures and the absence of tools integrating longitudinal clinical with molecular data at scale. Autosomal dominant polycystic kidney disease (ADPKD), the most common monogenic cause of kidney failure, exemplifies this gap given its phenotypic complexity and the need for individualized treatment decisions.
An in-depth analysis of the molecular changes induced by short-term calorie restriction before living kidney donation
|
Abstract Aging reduces cellular resilience and increases susceptibility to organ injury, notably acute kidney injury (AKI). Ischemia-reperfusion injury (IRI) influences outcomes after kidney transplantation. In animal models, short-term calorie restriction (CR) extends lifespan and protects kidneys from IRI, but translation to patients is limited due to incomplete mechanistic insight. This study examined clinical and molecular effects of short-term CR in living kidney donors.
By Martin R. Späth, Sita Arjune, Katrin Bohl, Markus M. Rinschen, Christine S. Falk, Philipp Antczak, Franziska Grundmann, Torsten Kubacki, Michael Ignarski, Felix C. Koehler, Kathrin Kaufmann, Malte P. Bartram, Tristan Wagner, Michael Thomas, Adam Wahida, Christoph Schmaderer, Stephan Kemmner, Christine Kurschat, Thomas Benzing, Dirk L. Stippel, Volker Burst, Roman-Ulrich Müller, K. Johanna R. Hoyer-Allo, Jan Wilm Lackmann
|
Nature
Verified
Targeted removal of soluble Fms-like tyrosine kinase 1 in very preterm preeclampsia: a pilot trial
|
Abstract Soluble Fms-like tyrosine kinase 1 (sFlt-1), a protein secreted by the placenta, plays a central role in the pathogenesis of preeclampsia—a life-threatening pregnancy complication for which no disease-specific treatment currently exists. We developed a strategy to selectively deplete circulating sFlt-1 and then conducted a single-arm, open-label trial to reduce circulating sFlt-1 in women with very preterm preeclampsia. The primary endpoints were safety and tolerability.
By Ravi I. Thadhani, Thomas F. Hiemstra, Manu Vatish, Holger Stepan, Ana Sofia Cerdeira, Jeremy C. Brockelsby, Tim James, Massimiliano Lia, Alissa Cornelis, Elena Krause, Martin R. Späth, Berthold Grüttner, Polina Todorova, Henning Hagmann, Kristen R. Yeung, Bei Xu, Scott J. Heffernan, Suzanne Pears, Richard Waugh, John Thompson, Jim Iliopoulos, Neroli Sunderland, Murray C. Killingsworth, Angela Makris, Annemarie Hennessy, Agnes Lo, Adelene Y. Tan, Paul Kussie, Yuchiao Chang, Linda Hanssens, Stefan Miltenyi, Thomas Benzing, S. Ananth Karumanchi
|
Nature
Verified
Deutsche Medizinische Wochenschrift / Abstract
Multimorbidität betrifft fast alle Patienten mit chronischen Nierenkrankheiten (CKD), häufig mit kardiovaskulären Erkrankungen wie Herzinsuffizienz, Vorhofflimmern, koronarer Herzkrankheit, Schlaganfall und vaskulärer Demenz sowie einer erhöhten Infektionsgefahr (z.B. COVID-19). Kardiometabolische Erkrankungen nehmen im Verlauf zu, während Lungen- und psychische Erkrankungen anfangs dominieren.
Chronic kidney disease promotes ageing in a multiorgan disease network - Nature Reviews Nephrology
Human ageing trajectories are highly individual and dependent on genetic and non-genetic factors. An analysis of the interconnectivity of distinct age-related chronic diseases shows that organ-specific chronic diseases accelerate the ageing of other organ systems, which has important implications for mortality. Notably, chronic kidney disease was identified a highly important risk factor for the ageing of other organ systems. Refers to Tian, Y. E. et al.
Ageing-associated changes in transcriptional elongation influence longevity - Nature
Abstract Physiological homeostasis becomes compromised during ageing, as a result of impairment of cellular processes, including transcription and RNA splicing1,2,3,4. However, the molecular mechanisms leading to the loss of transcriptional fidelity are so far elusive, as are ways of preventing it. Here we profiled and analysed genome-wide, ageing-related changes in transcriptional processes across different organisms: nematodes, fruitflies, mice, rats and humans.
Accelerated lysine metabolism conveys kidney protection in salt-sensitive hypertension - Nature Communications
|
Abstract Hypertension and kidney disease have been repeatedly associated with genomic variants and alterations of lysine metabolism. Here, we combined stable isotope labeling with untargeted metabolomics to investigate lysine’s metabolic fate in vivo. Dietary 13C6 labeled lysine was tracked to lysine metabolites across various organs. Globally, lysine reacts rapidly with molecules of the central carbon metabolism, but incorporates slowly into proteins and acylcarnitines.
By Markus M. Rinschen, Oleg Palygin, Xavier Domingo-Almenara, Michael A. Schafroth, Fatih Demir, Thomas Benzing, Enrique Saez, Benjamin Cravatt, Marcus Kruger, H. Paul Benton, Gary Siuzdak, Alexander Staruschenko, Ashraf El-Meanawy, Lashodya V. Dissanayake, Daria Golosova, Johannes Jaegers, Martin Hoehne, Markus Bleich
|
Nature
Verified
RNA-binding proteins and their role in kidney disease - Nature Reviews Nephrology
Author notes These authors contributed equally: Michael Ignarski, Roman-Ulrich Müller.
Insights into Glomerular Filtration and Albuminuria
logo-32 logo-40 logo-60 This article is available to subscribers. Subscribe now. Already have an account? Sign in Review ArticleFree Preview List of authors. Thomas Benzing, M.D., and David Salant, M.D. Related Articles Chronic kidney diseases generally arise from a disordered kidney filtration barrier within glomeruli. This review describes the roles of glomerular capillary pressure, the glomerular basement membrane, and podocytes in regulating glomerular filtration and permeability.
Glomerular podocytes in kidney health and disease
Chronic kidney disease affects more than 10% of the world's population. 90% of all cases are attributed to glomerular diseases. Therefore, understanding the underpinnings of glomerular structure, physiology, and pathophysiology is of priority in overcoming the clinical, societal, and economic consequences of chronic kidney disease. To read this article in full you will need to make a payment Subscribe to The Lancet References Levin A Tonelli M Bonventre J et al.
Pre-eclampsia: pathogenesis, novel diagnostics and therapies
1. Wallis, A. B., Saftlas, A. F., Hsia, J. & Atrash, H. K. Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987–2004. Am. J. Hypertens. 21, 521–526 (2008). PubMed Google Scholar 2. Duley, L. The global impact of pre-eclampsia and eclampsia. Semin. Perinatol. 33, 130–137 (2009). PubMed Google Scholar 3. Ananth, C. V., Keyes, K. M. & Wapner, R. J. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ 347, f6564 (2013).
Cysteine S-glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ)
Author contributions: RKG, BS and TB conceived the idea for the project, analyzed the results, and wrote most of the paper. RKG, BW, MJ, MB, MHA and MR conducted most of the experiments. MaJ conducted in vivo I/R experiments. All authors reviewed the results and approved the final version of the manuscript.
Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice
Recently, the European Medicines Agency approved the use of the vasopressin V2 receptor antagonist tolvaptan to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adult patients with chronic kidney disease stages 1–3 at initiation of treatment with evidence of rapidly progressing disease.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Thomas
Contact Thomas, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack